Resolving the ambiguous binding site of quercetin at the calcineurin subunit junction using funnel metadynamics with deep learning collective variables
Clinical Snapshot
PICO Framework
| P — Population | Calcineurin protein structure and quercetin ligand binding interactions |
| I — Intervention | Funnel metadynamics with deep learning collective variables computational modeling |
| C — Comparator | Three experimentally suggested binding sites and FRET assay measurements |
| O — Outcomes | Binding site identification, free energy of binding (-8.36 ± 0.60 kcal/mol), ligand-tryptophan distance correlations (r² = 0.85) |
Bottom Line
This computational study successfully resolved the ambiguous binding site of quercetin at the calcineurin subunit junction using advanced deep learning-enhanced molecular dynamics simulations. The methodology demonstrated excellent correlation with experimental data (r² = 0.85) and identified specific amino acid residues involved in binding. The calculated binding energy (-8.36 ± 0.60 kcal/mol) aligns well with experimental measurements. These findings provide crucial structural insights for developing immunophilin-independent calcineurin inhibitors, potentially offering advantages over current immunosuppressive drugs by avoiding their associated adverse effects and pharmacokinetic variability. The study establishes a robust computational framework applicable to other challenging protein-ligand binding problems in drug discovery.
Key Findings
P Value: Not reported in abstract
Effect Size: Free energy of binding -8.36 ± 0.60 kcal/mol
Primary Outcome: Successful identification of quercetin binding site at calcineurin subunit junction
Nnt Or Sensitivity: Correlation coefficient r² = 0.85 with experimental FRET measurements
Confidence Interval: ±0.60 kcal/mol for binding energy
Clinical Application
Provides computational framework applicable to other challenging protein-ligand systems Relevant to Australian pharmaceutical research institutions and TGA drug development pathways for novel immunosuppressants Drug discovery researchers developing calcineurin inhibitors for immunosuppression
Abstract
Calcineurin represents a prominent target for immunosuppressive drugs, where conventional macrocyclic inhibitors utilize an immunophilin-dependent mechanism for their inhibition but are consequently hindered by adverse effects and variable pharmacokinetics. The flavonoid quercetin has been shown to inhibit calcineurin in a non-competitive, immunophilin-independent manner, but its exact binding site remains ambiguous at the junction between calcineurin subunits A and B, with the open solvent-exposed nature of this region proving challenging to model. In this study, we employ funnel metadynamics with collective variables derived from a deep learning model to identify the binding site of quercetin. A selective strategy using multiple simulations with stricter funnel definitions and a smaller number of carefully chosen descriptors for model training proved more effective than a broad-based approach. These simulations were able to effectively distinguish the binding site of quercetin from three experimentally suggested sites, with a calculated free energy of binding of -8.36 ± 0.60 kcal/mol showing excellent agreement with experiment. Ligand-tryptophan distances similarly corroborated measurements from FRET assays with a r2 of 0.85. The corresponding binding pose showed that quercetin inserts itself into a channel between Arg122, Gly123, Tyr124 on one side and Phe160, Thr161, and Asn345 on the other, stabilizing its binding through a network of hydrogen bonds. The findings of this study provide insights into the modelling of challenging binding sites and ligands using deep learning driven metadynamics simulations and provide the foundations for rational development of immunophilin-independent inhibitors of calcineurin.
References
- 1.Loo, J. S. E., & Yau, M. Q. (2026). Resolving the ambiguous binding site of quercetin at the calcineurin subunit junction using funnel metadynamics with deep learning collective variables. Journal of Computer-Aided Molecular Design. https://doi.org/10.1073/pnas.1303186110
Related Research
CPT: pharmacometrics & systems pharmacology
Structured Schemas for Provenance-Rich, LLM-Assisted QSP Model Calibration
2 Aug 2026
Journal of pharmacokinetics and pharmacodynamics
Diffusion models for virtual populations and pharmacometric simulations
1 Aug 2026
Journal of chemical information and modeling
HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases
29 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service